Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Pneumonia Vaccines Market, by Vaccine Type
1.4.2 North America Pneumonia Vaccines Market, by Product Type
1.4.3 North America Pneumonia Vaccines Market, by Sector
1.4.4 North America Pneumonia Vaccines Market, by Distribution Channel
1.4.5 North America Pneumonia Vaccines Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Pneumonia Vaccines Market by Vaccine Type
3.1 North America Pneumococcal Conjugate Vaccine (PCV) Market by Region
3.2 North America Pneumococcal Polysaccharide Vaccine (PPSV/PPV) Market by Region
Chapter 4. North America Pneumonia Vaccines Market by Product Type
4.1 North America Prevnar 13 Market by Region
4.2 North America Synflorix Market by Region
4.3 North America Pneumovax 23 Market by Region
Chapter 5. North America Pneumonia Vaccines Market by Sector
5.1 North America Private sector Market by Region
5.2 North America Public sector Market by Region
Chapter 6. North America Pneumonia Vaccines Market by Distribution Channel
6.1 North America Distribution Partner Companies Market by Region
6.2 North America Non-Governmental Organizations (NGO) Market by Region
6.3 North America Government Authorities Market by Region
Chapter 7. North America Pneumonia Vaccines Market by Country
7.1 USA Pneumonia Vaccines Market
7.1.1 USA Pneumonia Vaccines Market by Vaccine Type
7.1.2 USA Pneumonia Vaccines Market by Product Type
7.1.3 USA Pneumonia Vaccines Market by Sector
7.1.4 USA Pneumonia Vaccines Market by Distribution Channel
7.2 Canada Pneumonia Vaccines Market
7.2.1 Canada Pneumonia Vaccines Market by Vaccine Type
7.2.2 Canada Pneumonia Vaccines Market by Product Type
7.2.3 Canada Pneumonia Vaccines Market by Sector
7.2.4 Canada Pneumonia Vaccines Market by Distribution Channel
7.3 Mexico Pneumonia Vaccines Market
7.3.1 Mexico Pneumonia Vaccines Market by Vaccine Type
7.3.2 Mexico Pneumonia Vaccines Market by Product Type
7.3.3 Mexico Pneumonia Vaccines Market by Sector
7.3.4 Mexico Pneumonia Vaccines Market by Distribution Channel
7.4 Rest of North America Pneumonia Vaccines Market
7.4.1 Rest of North America Pneumonia Vaccines Market by Vaccine Type
7.4.2 Rest of North America Pneumonia Vaccines Market by Product Type
7.4.3 Rest of North America Pneumonia Vaccines Market by Sector
7.4.4 Rest of North America Pneumonia Vaccines Market by Distribution Channel
Chapter 8. Company Profiles
8.1 GLAXOSMITHKLINE PLC (GSK)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.1 Recent strategies and developments:
8.1.1.1 Collaboration, partnerships and agreements:
8.1.1.2 Expansion:
8.1.2 SWOT Analysis
8.2 LG Corporation (LG Chemicals Ltd.)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 SWOT Analysis
8.3 Panacea Biotec Limited
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Collaboration, partnerships and agreements:
8.3.6 SWOT Analysis
8.4 Pfizer, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Collaboration, partnerships and agreements:
8.4.5.2 Product launch:
8.4.6 SWOT Analysis
8.5 PnuVax Incorporated
8.5.1 Company Overview
8.6 Poonawalla Investments & Industries Pvt. Ltd. (Serum Institute of India Pvt. Ltd.)
8.6.1 Company Overview
8.7 Shenzhen Kangtai Biological Products Co., Ltd. (Beijing Minhai Biotechnology Corporation Limited)
8.7.1 Company Overview
8.8 SK Holdings Co., Ltd. (SK Bioscience, Inc.)
8.8.1 Company overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expenses
8.9 Walvax Biotechnology Co., Ltd.
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Product launch:
8.1 Merck & Co., Inc.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental and Regional Analysis
8.10.4 Research & Development Expenses
8.10.5 Recent strategies and developments:
8.10.5.1 Collaboration, partnerships and agreements:
8.10.5.2 Product launch:
8.10.6 SWOT Analysis
Unique Offerings 